These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37004837)

  • 41. MRI Radiomic Features: Association with Disease-Free Survival in Patients with Triple-Negative Breast Cancer.
    Kim S; Kim MJ; Kim EK; Yoon JH; Park VY
    Sci Rep; 2020 Feb; 10(1):3750. PubMed ID: 32111957
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of heterogeneity of peritumoral T2 hyperintensity in patients with pretreatment glioblastoma: Prognostic value of MRI-based radiomics.
    Choi Y; Ahn KJ; Nam Y; Jang J; Shin NY; Choi HS; Jung SL; Kim BS
    Eur J Radiol; 2019 Nov; 120():108642. PubMed ID: 31546124
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Applicability of a prognostic CT-based radiomic signature model trained on stage I-III non-small cell lung cancer in stage IV non-small cell lung cancer.
    de Jong EEC; van Elmpt W; Rizzo S; Colarieti A; Spitaleri G; Leijenaar RTH; Jochems A; Hendriks LEL; Troost EGC; Reymen B; Dingemans AC; Lambin P
    Lung Cancer; 2018 Oct; 124():6-11. PubMed ID: 30268481
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radiomic nomogram based on MRI to predict grade of branching type intraductal papillary mucinous neoplasms of the pancreas: a multicenter study.
    Cui S; Tang T; Su Q; Wang Y; Shu Z; Yang W; Gong X
    Cancer Imaging; 2021 Mar; 21(1):26. PubMed ID: 33750453
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intrinsic radiomic expression patterns after 20 Gy demonstrate early metabolic response of oropharyngeal cancers.
    Lafata KJ; Chang Y; Wang C; Mowery YM; Vergalasova I; Niedzwiecki D; Yoo DS; Liu JG; Brizel DM; Yin FF
    Med Phys; 2021 Jul; 48(7):3767-3777. PubMed ID: 33959972
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vulnerabilities of radiomic signature development: The need for safeguards.
    Welch ML; McIntosh C; Haibe-Kains B; Milosevic MF; Wee L; Dekker A; Huang SH; Purdie TG; O'Sullivan B; Aerts HJWL; Jaffray DA
    Radiother Oncol; 2019 Jan; 130():2-9. PubMed ID: 30416044
    [TBL] [Abstract][Full Text] [Related]  

  • 47. External validation of an
    Mori M; Deantoni C; Olivieri M; Spezi E; Chiara A; Baroni S; Picchio M; Del Vecchio A; Di Muzio NG; Fiorino C; Dell'Oca I
    Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1329-1336. PubMed ID: 36604325
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development and External Validation of a PET Radiomic Model for Prognostication of Head and Neck Cancer.
    Noortman WA; Aide N; Vriens D; Arkes LS; Slump CH; Boellaard R; Goeman JJ; Deroose CM; Machiels JP; Licitra LF; Lhommel R; Alessi A; Woff E; Goffin K; Le Tourneau C; Gal J; Temam S; Delord JP; van Velden FHP; de Geus-Oei LF
    Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345017
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pre-operative radiomics model for prognostication in resectable pancreatic adenocarcinoma with external validation.
    Healy GM; Salinas-Miranda E; Jain R; Dong X; Deniffel D; Borgida A; Hosni A; Ryan DT; Njeze N; McGuire A; Conlon KC; Dodd JD; Ryan ER; Grant RC; Gallinger S; Haider MA
    Eur Radiol; 2022 Apr; 32(4):2492-2505. PubMed ID: 34757450
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The prognostic value of CT-based image-biomarkers for head and neck cancer patients treated with definitive (chemo-)radiation.
    Zhai TT; Langendijk JA; van Dijk LV; Halmos GB; Witjes MJH; Oosting SF; Noordzij W; Sijtsema NM; Steenbakkers RJHM
    Oral Oncol; 2019 Aug; 95():178-186. PubMed ID: 31345388
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oropharyngeal squamous cell carcinoma: radiomic machine-learning classifiers from multiparametric MR images for determination of HPV infection status.
    Suh CH; Lee KH; Choi YJ; Chung SR; Baek JH; Lee JH; Yun J; Ham S; Kim N
    Sci Rep; 2020 Oct; 10(1):17525. PubMed ID: 33067484
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Radiomic subtyping improves disease stratification beyond key molecular, clinical, and standard imaging characteristics in patients with glioblastoma.
    Kickingereder P; Neuberger U; Bonekamp D; Piechotta PL; Götz M; Wick A; Sill M; Kratz A; Shinohara RT; Jones DTW; Radbruch A; Muschelli J; Unterberg A; Debus J; Schlemmer HP; Herold-Mende C; Pfister S; von Deimling A; Wick W; Capper D; Maier-Hein KH; Bendszus M
    Neuro Oncol; 2018 May; 20(6):848-857. PubMed ID: 29036412
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An MRI-based radiomics signature and clinical characteristics for survival prediction in early-stage cervical cancer.
    Zheng RR; Cai MT; Lan L; Huang XW; Yang YJ; Powell M; Lin F
    Br J Radiol; 2022 Jan; 95(1129):20210838. PubMed ID: 34797703
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development and validation of a 6-gene signature for the prognosis of loco-regional control in patients with HPV-negative locally advanced HNSCC treated by postoperative radio(chemo)therapy.
    Patil S; Linge A; Grosser M; Lohaus F; Gudziol V; Kemper M; Nowak A; Haim D; Tinhofer I; Budach V; Guberina M; Stuschke M; Balermpas P; Rödel C; Schäfer H; Grosu AL; Abdollahi A; Debus J; Ganswindt U; Belka C; Pigorsch S; Combs SE; Boeke S; Zips D; Baretton GB; Baumann M; Krause M; Löck S;
    Radiother Oncol; 2022 Jun; 171():91-100. PubMed ID: 35429503
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Conventional magnetic resonance imaging-based radiomic signature predicts telomerase reverse transcriptase promoter mutation status in grade II and III gliomas.
    Jiang C; Kong Z; Zhang Y; Liu S; Liu Z; Chen W; Liu P; Liu D; Wang Y; Lyu Y; Zhao D; Wang Y; You H; Feng F; Ma W
    Neuroradiology; 2020 Jul; 62(7):803-813. PubMed ID: 32239241
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Machine learning and radiomic phenotyping of lower grade gliomas: improving survival prediction.
    Choi YS; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Jain R; Lee SK
    Eur Radiol; 2020 Jul; 30(7):3834-3842. PubMed ID: 32162004
    [TBL] [Abstract][Full Text] [Related]  

  • 57. DWI-based radiomic signature: potential role for individualized adjuvant chemotherapy in intrahepatic cholangiocarcinoma after partial hepatectomy.
    Yang Y; Zou X; Zhou W; Yuan G; Hu D; Shen Y; Xie Q; Zhang Q; Kuang D; Hu X; Li Z
    Insights Imaging; 2022 Mar; 13(1):37. PubMed ID: 35244793
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radiomic signature as a predictive factor for lymph node metastasis in early-stage cervical cancer.
    Kan Y; Dong D; Zhang Y; Jiang W; Zhao N; Han L; Fang M; Zang Y; Hu C; Tian J; Li C; Luo Y
    J Magn Reson Imaging; 2019 Jan; 49(1):304-310. PubMed ID: 30102438
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identifying
    Li J; Liu Y; Dong W; Zhou Y; Wu J; Luan K; Qi L
    Quant Imaging Med Surg; 2022 Mar; 12(3):1893-1908. PubMed ID: 35284267
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Nomogram of MRI-based Radiomics with Complementary Visual Features by Machine Learning Improves Stratification of Glioblastoma Patients: A Multicenter Study.
    Xu Y; He X; Li Y; Pang P; Shu Z; Gong X
    J Magn Reson Imaging; 2021 Aug; 54(2):571-583. PubMed ID: 33559302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.